Exchange:
Industry: Pharmaceuticals & Biotechnology
Last Trade: 4:00 PM ET 5/21/2013
Last 10 Quotes:
What's This?
Upgrades & Downgrades History
| Date | Analyst | Action | From | To | Price Target |
|---|---|---|---|---|---|
| 4/12/2012 | UBS | Initiated | Buy | 43 | |
| 3/26/2012 | Canaccord Genuity | Initiated | Buy | 43 | |
| 3/19/2012 | Brean Murray | Upgraded | Hold | Buy | 41 |
| 2/13/2012 | RBC Capital Mkts | Reiterated | Outperform | 40 | |
| 10/31/2011 | Summer Street Research | Reiterated | Buy | 40 | |
| 9/28/2011 | Deutsche Bank | Upgraded | Hold | Buy | 40 |
| 9/16/2011 | RBC Capital Mkts | Initiated | Outperform | 36 | |
| 4/29/2011 | Collins Stewart | Reiterated | Buy | 33 | |
| 12/2/2010 | UBS | Downgraded | Buy | Neutral | 28 |
| 11/1/2010 | Morgan Joseph | Downgraded | Buy | Hold | |
| 10/25/2010 | Wedbush | Reiterated | Neutral | 27 | |
| 9/13/2010 | Dawson James | Initiated | Neutral | 26 | |
| 9/1/2010 | Morgan Joseph | Upgraded | Hold | Buy | 25 |
| 3/12/2010 | Piper Jaffray | Initiated | Neutral | ||
| 2/9/2010 | Roth Capital | Upgraded | Hold | Buy | 23 |
| 2/8/2010 | Brean Murray | Downgraded | Buy | Hold | |
| 2/4/2010 | Roth Capital | Reiterated | Hold | 23 | |
| 1/8/2010 | Morgan Joseph | Downgraded | Buy | Hold | |
| 12/9/2009 | Collins Stewart | Upgraded | Hold | Buy | 22 |
| 10/29/2009 | Credit Suisse | Upgraded | Neutral | Outperform | |
| 10/19/2009 | Roth Capital | Downgraded | Buy | Hold | 17 |
| 10/8/2009 | Jefferies & Co | Reiterated | Buy | 20 | |
| 7/31/2009 | Wedbush Morgan | Upgraded | Underperform | Neutral | 20 |
| 7/31/2009 | Jefferies & Co | Reiterated | Buy | 18 | |
| 7/27/2009 | Roth Capital | Reiterated | Buy | 17 | |
| 5/20/2009 | Roth Capital | Reiterated | Buy | 18 | |
| 4/21/2009 | Morgan Joseph | Initiated | Buy | 20 | |
| 3/31/2009 | Thomas Weisel | Initiated | Market Weight | 14 | |
| 3/27/2009 | Piper Jaffray | Initiated | Neutral | ||
| 3/12/2009 | FTN Equity Capital | Initiated | Buy | ||
| 3/12/2009 | Leerink Swann | Reiterated | Outperform | 21 | |
| 3/4/2009 | Citigroup | Upgraded | Hold | Buy | 17 |
| 2/24/2009 | Roth Capital | Upgraded | Hold | Buy | |
| 2/23/2009 | Jefferies & Co | Reiterated | Buy | 16 | |
| 2/19/2009 | UBS | Reiterated | Buy | 20 | |
| 2/19/2009 | Benchmark | Downgraded | Buy | Hold | 14 |
| 2/19/2009 | Brean Murray | Reiterated | Buy | 20 | |
| 2/19/2009 | Roth Capital | Reiterated | Hold | 14 | |
| 2/19/2009 | Credit Suisse | Reiterated | Neutral | 19 | |
| 2/19/2009 | Collins Stewart | Downgraded | Buy | Hold | |
| 2/19/2009 | Wachovia | Downgraded | Outperform | Mkt Perform | |
| 1/9/2009 | Brean Murray | Initiated | Buy | 25 | |
| 1/7/2009 | Benchmark | Upgraded | Hold | Buy | 22 |
| 12/23/2008 | Stanford Research | Initiated | Hold | ||
| 12/15/2008 | Credit Suisse | Reiterated | Neutral | 23 | |
| 11/21/2008 | Citigroup | Upgraded | Hold | Buy | 22 |
| 10/29/2008 | Roth Capital | Reiterated | Hold | 16 | |
| 10/15/2008 | Benchmark | Downgraded | Buy | Hold | |
| 9/12/2008 | William Blair | Initiated | Outperform | ||
| 8/22/2008 | Rodman & Renshaw | Reiterated | Mkt Outperform | 36 |
